| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.11B | +23.5% |
| Cost of Revenue | $926.9M | +29.4% |
| Gross Profit | $1.18B | +19.2% |
| R&D Expense | $91.3M | +21.2% |
| SG&A Expense | $1.03B | +23.7% |
| Operating Income | -$775.7M | -1080.5% |
| Interest Expense | $57.1M | +189.1% |
| Pre-tax Income | -$822.9M | -1125.9% |
| Income Tax | $4.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.2M | +33.1% |
| Accounts Receivable | $407.0M | +39.6% |
| Inventory | $547.1M | +16.7% |
| Current Assets | $1.15B | +27.9% |
| Total Assets | $4.72B | +4.6% |
| Current Liabilities | $529.0M | +43.1% |
| Long-term Debt | $1.33B | +185.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $113.5M | -15.9% |
| Capital Expenditures | $180.7M | +47.9% |
| Investing Cash Flow | -$955.5M | -294.1% |
| Financing Cash Flow | $846.8M | +562.6% |
| Free Cash Flow | -$67.2M | -626.5% |
| +133.8% |
| Net Income | -$825.5M | -2381.9% |
| EPS (Basic) | -$14.93 | -2347.5% |
| EPS (Diluted) | -$14.93 | -2347.5% |
| Total Liabilities |
| $2.15B |
| +97.9% |
| Stockholders' Equity | $2.56B | -25.0% |